NEW YORK (GenomeWeb News) – Genomics services firm Expression Analysis today announced it has received certification under the Clinical Laboratory Improvement Act from the Centers for Medicare and Medicaid Services.
"For 10 years EA has delivered exceptional services and our clients have come to expect the highest quality work with the ability to overcome challenging scientific hurdles," Steve McPhail, president and CEO of EA, said in a statement. "With this certification, our clients can be confident of our continued commitment to their success."
According to Karen Michailo, senior director of marketing for EA, the company has been operating under CLIA guidelines for a number of years, and “this was just the next natural step, to get certified.”
She added that the company is “exploring numerous different tests,” and eventually will target clinicians for its services, but declined to elaborate, citing ongoing collaborations with undisclosed companies.
Based in Durham, NC, EA provides services to pharma, biotech, and the academic, government, and non-profit markets. The range of services available includes experiment design, next-generation sequencing, gene expression profiling, genotyping, and others.
The company was founded in August 2001 as it commercialized the operations of the Microarray Core Facility at Duke University Medical Center.